Oct 20, 2020 / 01:30PM GMT
Operator
Good day, and welcome to the Sartorius and Sartorius Stedim Biotech Conference Call on the 9 months 2020 results. Today's conference is being recorded. At this time, I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO. Please go ahead, sir.
Joachim Kreuzburg - Sartorius Stedim Biotech S.A. - Chairman & CEO
Thank you very much. Welcome, and good day also from our side here to our conference call on the 9 months results of Sartorius and Sartorius Stedim Biotech. As always, we first would like to walk you through the results for the Sartorius Group, and then thereafter through those for Sartorius Stedim Biotech.
I would like to kick it off by talking about -- briefly about the main highlights of our results for the first 9 months. Sales revenues, order intake and earnings all have been up with quite significant double-digit growth rates, particularly the EPS division continued to expand very dynamically with a very strong performance also in the recent 3 months, strong underlying organic growth and then additional tailwinds from
Q3 2020 Sartorius AG Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot